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Structure of cellular ESCRT-III spirals and
their relationship to HIV budding
Anil G Cashikar†, Soomin Shim†, Robyn Roth, Michael R Maldazys, John E Heuser,
Phyllis I Hanson*
Department of Cell Biology and Physiology, Washington University School of Medicine,
St. Louis, United States

Abstract The ESCRT machinery along with the AAA+ ATPase Vps4 drive membrane scission for
trafficking into multivesicular bodies in the endocytic pathway and for the topologically related
processes of viral budding and cytokinesis, but how they accomplish this remains unclear. Using
deep-etch electron microscopy, we find that endogenous ESCRT-III filaments stabilized by depleting
cells of Vps4 create uniform membrane-deforming conical spirals which are assemblies of specific
ESCRT-III heteropolymers. To explore functional roles for ESCRT-III filaments, we examine HIV-1
Gag-mediated budding of virus-like particles and find that depleting Vps4 traps ESCRT-III filaments
around nascent Gag assemblies. Interpolating between the observed structures suggests a new role
for Vps4 in separating ESCRT-III from Gag or other cargo to allow centripetal growth of a neck
constricting ESCRT-III spiral.
DOI: 10.7554/eLife.02184.001
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Vesicle formation requires machinery to identify cargo, deform the membrane and release a vesicle.
How cytoplasmic proteins cooperate to form vesicles that mediate transport between organelles is
well defined. Less well understood is how cytoplasmic proteins drive the topologically reverse process
of creating intralumenal vesicles (ILVs) in multivesicular bodies (MVBs). Studies over the past decade
have shown that a set of over 30 proteins are responsible for ILV formation and are also required
for the topologically similar processes of viral budding and cytokinesis (Hurley, 2010; Hanson and
Cashikar, 2012; Sundquist and Krausslich, 2012; Henne et al., 2013; McCullough et al., 2013).
Most are components of ESCRT (endosomal sorting complex required for transport) complexes.
The multisubunit ESCRT-0, -I, and -II complexes are thought to recognize cargo and initiate vesicle
formation, while ESCRT-III proteins and the AAA+ ATPase Vps4 that acts on them promote membrane
remodeling and scission both on MVBs and the plasma membrane. A subject of much current interest
is how, exactly, ESCRT-III and Vps4 drive these events.
Seven ESCRT-III proteins in yeast and 12 in humans are structurally similar to each other but are
not redundant for pathway function (Morita et al., 2010, 2011; Peel et al., 2011). ESCRT-III proteins
cycle between an inactive or closed monomeric state in the cytoplasm and an activated or open state
in which they polymerize into filaments on the membrane (Babst et al., 2002; Lin et al., 2005;
Zamborlini et al., 2006; Shim et al., 2007; Hanson et al., 2008). ESCRT-II initiates ESCRT-III assembly
on the MVB by binding to Vps20/CHMP6 (Babst et al., 2002; Teis et al., 2010) while virally encoded
sequence motifs bind ESCRT-I and/or Alix which in turn promote ESCRT-III assembly during viral budding (von Schwedler et al., 2003; Strack et al., 2003). Once nucleated, ESCRT-III polymers grow
by recruiting other subunits (Babst et al., 2002; Shim et al., 2007; Teis et al., 2008; Saksena et al.,
2009). Reconstituting ILV formation on giant unilamellar vesicles established that ESCRT-III proteins alone can promote vesicle release (Wollert et al., 2009; Wollert and Hurley, 2010) although
studies in yeast suggest that they normally do this in cooperation with Vps4 (Nickerson et al., 2010;
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eLife digest Cells contain compartments called organelles that are enclosed within membranes
similar to the plasma membrane that surrounds the cell itself. Cells police the proteins on their
membranes and move old or damaged proteins into a type of organelle called an endosome.
This involves the membrane folding in on itself to form a multivesicular body.
The multivesicular bodies deliver their contents to organelles called lysosomes where the old
proteins are destroyed. Although it is known that over 30 proteins are involved in the formation
of multivesicular bodies, many aspects of how they operate are not well understood. Moreover,
disruptions to this process contribute to a large number of diseases including forms of cancer and
neurodegeneration. Importantly, the same proteins are hijacked by viruses such as HIV to help them
escape from the cells they have infected.
Most of the proteins involved in forming multivesicular bodies are part of the ESCRT (Endosomal
Sorting Complex Required for Transport) system of proteins. A special set of these proteins—
ESCRT-III—is thought to cut the membrane to release vesicles and viruses, as well as helping the
membrane to deform.
Previously, researchers have been unsure how the ESCRT-III complex works because it has a short
lifespan and is too small to see on cellular membranes using standard techniques. Now Cashikar,
Shim et al. have used a technique called deep-etch electron microscopy in combination with gene
knockdown strategies to reveal the structure of the ESCRT-III complex inside cells.
A protein called Vps4 is known to recycle ESCRT-III complexes, so Cashikar, Shim et al. studied
cells in which the levels of Vps4 had been depleted in order to increase the lifespan of ESCRT-III
complexes. In these cells filaments made of ESCRT-III complexes tended to form conical spirals that
matched the size and shape of the vesicles and viruses ESCRT-III is thought to produce. ESCRT-III
filaments also accumulated as rings around the molecules destined for incorporation into a vesicle
or virus. This indicated a new role for Vps4: it separates ESCRT-III from the contents of the vesicle,
leaving it free to form a spiral that drives release of the vesicle or virus from the cell.
The next challenge will be to test the predictions of this model using techniques that can capture
individual vesicle formation events in real time. Understanding the function of ESCRT-III in greater
detail may suggest ways to manipulate this pathway to limit the replication of viruses or the
degradation of membrane proteins.
DOI: 10.7554/eLife.02184.002

Adell et al., 2014). In addition to Vps20/CHMP6 as a nucleator, specific roles attributed to individual
ESCRT-III proteins include cargo confinement by Snf7/CHMP4 (Teis et al., 2008), polymer capping by
Vps24/CHMP3 (Saksena et al., 2009), and Vps4 recruitment by Vps2/CHMP2 and Did2/CHMP1 (Lata
et al., 2008; Saksena et al., 2009; Davies et al., 2010; Adell et al., 2014). ESCRT-III polymers are
remodeled and disassembled by the AAA ATPase Vps4 before (Nickerson et al., 2010; Baumgartel
et al., 2011; Jouvenet et al., 2011; Adell et al., 2014) and/or after (Wollert et al., 2009; Wollert and
Hurley, 2010) membrane scission, returning individual subunits to their closed state in the cytoplasm.
Structural studies demonstrate that ESCRT-III proteins each consist of a ∼7 nm helical hairpin (α1–α2)
stabilized and regulated by four or more short helices (α3–α6) (Muziol et al., 2006; Bajorek et al.,
2009; Xiao et al., 2009; Martinelli et al., 2012). α5–α6 and surrounding sequences are responsible
for autoinhibition and thereby regulate membrane binding and polymer assembly (Zamborlini et al.,
2006; Shim et al., 2007; Bajorek et al., 2009). In their active or open state, ESCRT-III proteins polymerize in vitro and in vivo using a number of different protein–protein interfaces (Muziol et al., 2006;
Ghazi-Tabatabai et al., 2008; Bajorek et al., 2009; Xiao et al., 2009; Morita et al., 2011). Snf7/
CHMP4 is the most abundant ESCRT-III protein, and forms membrane-associated polymers in vitro and
in transfected cells (Hanson et al., 2008; Teis et al., 2008; Fyfe et al., 2011; Henne et al., 2012).
Electron microscopy (EM) shows that Snf7/CHMP4 polymers are curved filaments <5 nm in diameter
(Ghazi-Tabatabai et al., 2008; Hanson et al., 2008; Pires et al., 2009; Henne et al., 2012). Other
ESCRT-III proteins shown to assemble in vitro into a variety of mostly tubular structures include
CHMP2A and CHMP3 (Lata et al., 2008; Bajorek et al., 2009; Dobro et al., 2013; Effantin et al.,
2013), CHMP1B (Bajorek et al., 2009; Dobro et al., 2013), CHMP2B (Bodon et al., 2011), and Ist1
(Bajorek et al., 2009; Dobro et al., 2013). Finally, ∼17 nm filaments on the membrane in intercellular
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bridges before cytokinesis disappear when CHMP2A is missing, suggesting that they too might
represent a form of ESCRT-III polymer (Guizetti et al., 2011). These many views of ESCRT-III have led
to proposals for how it and Vps4 contribute to membrane scission during ILV formation, viral budding,
and cytokinesis (Fabbro et al., 2005; Lenz et al., 2009; Saksena et al., 2009; Wollert et al., 2009;
Elia et al., 2012; Henne et al., 2013; McCullough et al., 2013). However, much remains to be learned
about the assembly and functional roles of different types of ESCRT-III polymers in their own right and
in conjunction with Vps4.
For insight into ESCRT-III polymer structure in a physiological setting, we examined endogenous
machinery in cultured mammalian cells by deep-etch EM. We find that ESCRT-III heteropolymers stabilized by depleting Vps4A & B are membrane-attached filaments that frequently spiral to delineate
and fill circular domains ∼110 nm in diameter. Many of these spirals induce conical deformations
directed away from the cytoplasm. Filaments built from transfected proteins show that coassembly
of two ESCRT-III proteins (in this case Snf7/CHMP4A and CHMP2A) is required to create membrane
deforming ESCRT-III spirals. To define the relationship between ESCRT-III filaments and cargo, we
studied HIV-1 Gag-driven virus-like-particle (VLP) assembly. Notably, in cells depleted of Vps4, we find
that Gag assemblies are often encircled by ESCRT-III filaments. This suggests a previously unappreciated
role for Vps4 in remodeling ESCRT-III around cargo-containing membrane domains in addition to its
more canonical role in recycling ESCRT-III subunits.

Results and discussion
Depleting Vps4 in mammalian cells traps ESCRT-III polymers on
membranes
Endogenous ESCRT-III proteins including CHMP4A and CHMP2B are diffusely localized in cells with
little steady-state concentration on endosomes despite their known role in lumenal vesicle formation
(Figure 1A, left panels). This is not surprising given measurements in live cells showing that both they
and Vps4 are present for a few minutes or less at their site of action during viral particle release
(Baumgartel et al., 2011; Jouvenet et al., 2011) or cytokinetic abscission (Elia et al., 2012). To visualize ESCRT-III, we therefore set out to increase the lifetime of membrane associated polymers taking
advantage of the known role for Vps4 in mediating disassembly and recycling of ESCRT-III (Babst
et al., 1998; Lin et al., 2005). Depleting Vps4A & B, the two Vps4 proteins present in human cells,
by RNAi (Figure 1B) caused ESCRT-III proteins to redistribute onto puncta localized throughout the
cell (Figure 1A, middle panels). Sedimentation of detergent solubilized cell extracts further demonstrated that a significant fraction of ESCRT-III proteins accumulated in the detergent insoluble fraction
characteristic of polymerized ESCRT-III (Figure 1C; Shim et al., 2007).
Deep-etch EM is particularly well suited to examining the morphology of the plasma membrane
(Heuser, 2000), and although many ESCRT-III puncta were on endosome like structures throughout
the cytoplasm, a subset appeared at the edge of the cell and remained associated with unroofed
plasma membranes (Figure 1A, right panels). Their presence could reflect a role for ESCRT-III in creating outwardly-directed vesicles known as ectosomes that bud from the plasma membrane (Stein and
Luzio, 1991; Nabhan et al., 2012; Choudhuri et al., 2014; Jimenez et al., 2014). Alternatively, ESCRT-III
puncta could be transferred to the plasma membrane by MVB exocytosis (Thery, 2011). Finally, ESCRTIII may have some other, potentially structural, role on the plasma membrane. Importantly, the accessibility of the plasma membrane to deep-etch EM provided us with a starting point for studying the
structure of cellular ESCRT-III.

Endogenous ESCRT-III polymers form conical spirals
Deep-etch EM of plasma membranes from cultured cells depleted of Vps4A & B revealed unique filamentous assemblies intermingled among otherwise typical cytoskeletal structures, clathrin lattices,
and caveolae (Figure 2A). The new filaments were attached to the membrane and most clearly recognized in discrete spirals that often deformed the membrane into conical protrusions. Because these
filaments resemble previously described ESCRT-III polymers, we used antibodies recognizing several
ESCRT-III proteins and found that gold particles marking each of the proteins examined (CHMP6,
CHMP2B, and CHMP1B) bound on or near filaments and filament spirals but not elsewhere on
membranes from cells depleted of Vps4A & B (Figure 2B) or on membranes from control HeLa cells
(not shown). Fortuitous immunodecoration inside broken but not fully unroofed Vps4-depleted cells
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Figure 1. Effects of depleting Vps4 on ESCRT-III. (A) Localization of indicated ESCRT-III protein in HeLa cells
untreated or treated with Vps4A & Vps4B specific siRNA for ∼60 hr. Left and middle panels show maximum
intensity projections from confocal z-series through the cells. Right panel shows immunostaining of unroofed
plasma membranes from HEK293T cells treated with Vps4A & Vps4B siRNA. Scale bars represent 10 μm.
(B) Representative immunoblots comparing lysates from cells untreated or treated with siRNA targeting
Vps4A & Vps4B. (C) Immunoblots of detergent soluble (left) and insoluble (right) material from control or
Vps4A & Vps4B siRNA-treated HeLa cells.
DOI: 10.7554/eLife.02184.003

showed that eversions containing ESCRT-III were also present along the cell's top surface (Figure 2—
figure supplement 1). The apparent distribution of different ESCRT-III proteins on the filament spirals
was similar (Figure 2B and not shown), although generally predominant labeling near the perimeter
may reflect limited epitope accessibility toward the center of the spirals. This immunodecoration
argues against unique positioning of particular ESCRT-III proteins along the filaments, although higher
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Figure 2. ESCRT-III filaments form conical spirals on the plasma membrane of cells depleted of Vps4A & Vps4B.
(A) Survey view of the cytoplasmic surface of the plasma membrane from a HeLa cell unroofed ∼60 hr after
transfection with siRNA targeting Vps4A & Vps4B. Pseudocoloring shows clathrin (orange), caveolae (green),
and ESCRT-III spirals (yellow). Similar filament spirals were seen in siRNA treated HEK293T, U2OS, and MCF-7 cells
(not shown). (B) Immunodecoration of ESCRT-III proteins in spirals on Vps4-depleted HeLa cell plasma membranes.
Antibodies recognizing CHMP6 (left), CHMP2B (middle), and CHMP1B (right) detected with 18 nm gold that appears
white in these contrast reversed EM images. Use view glasses for 3D structure in both panels (left eye = red). Scale
bars represent 100 nm.
DOI: 10.7554/eLife.02184.004
The following figure supplements are available for figure 2:
Figure supplement 1. Immunodecoration of ESCRT-III proteins beneath protrusions from the cell surface.
DOI: 10.7554/eLife.02184.005

resolution studies and additional antibodies will be required to determine exactly where different
ESCRT-III proteins are present in each spiral.
The most striking and unexpected characteristic of these stabilized ESCRT-III filaments was their
frequent organization into spirals (Figure 3A,B). Other patterns including partial or complete rings
and meandering filaments were also seen but were less common. The overall diameter of the spiral
assemblies was 108 ± 30 nm (Figure 3C), with an average of four 360° turns in each spiral. The shape
of the spirals on the membrane varied, ranging from clearly conical to flat. The total length of the
filament in each spiral was 660 ± 350 nm. While Vps4-driven remodeling may normally keep filaments from reaching this length (Teis et al., 2008), these images set an upper limit on the size and
shape of endogenous ESCRT-III polymer that is smaller and more uniform than that of the extensive polymers seen in vitro (Lata et al., 2008; Bajorek et al., 2009; Henne et al., 2012) or in cells
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Figure 3. Structural characteristics of endogenous ESCRT-III spirals. (A) Survey views of filaments and spirals on
plasma membranes of HeLa cells depleted of Vps4A & Vps4B show range of shapes, filament diameter, and
direction of spiraling. Examples of abrupt changes in filament diameter are highlighted in color (thicker filaments in
magenta and thinner filaments in green) in right panel. Use view glasses for 3D structure (left eye = red). Scale bar
represents 100 nm. (B) Views of individual spirals with direction of spiral from perimeter towards center as shown.
Each box corresponds to 185 nm. (C) Outer diameter of spirals defined as conical or flat based on appearance in
3D (n = 184, 61% conical 108 ± 29 nm; 39% flat 102 ± 20 nm). (D) Distribution of filament widths measured at three
points per spiral.
DOI: 10.7554/eLife.02184.006

overexpressing specific components of ESCRT-III (Hanson et al., 2008; Bodon et al., 2011). ESCRT-III
assembly must therefore be controlled by something other than the availability of subunits. One possibility is that centripetal growth of a membrane-attached filament determines the diameter of the
final assembly. Interestingly, ESCRT-III spirals surround and cover an area of membrane that corresponds well with that needed to generate a vesicle ∼50 nm in diameter—the typical size of ILVs in
mammalian cells (Murk et al., 2003)—suggesting that an initial ESCRT-III circle might define the content of an incipient vesicle.
For insight into how ESCRT-III filaments grow on the membrane, we asked if they preferentially
spiral in one direction or the other. Surprisingly, we found both left- and right-handed spirals even in
the same field of view (Figure 3). This was true both for obviously conical and flat spirals. Even without
knowing precisely how subunits are arranged within the filaments, it is clear that changes along the
spiral have the potential to affect positioning of functionally important motifs in the ESCRT-III proteins.
For example, changes in the recently described N-terminal membrane insertion motif (Buchkovich
et al., 2013) could contribute to membrane deformation.
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The apparent diameter of the finest filaments in ESCRT-III spirals was ∼4 nm (Figure 3D). Because
individual ESCRT-III proteins contain a ∼7 nm helical hairpin that is 3–4 nm wide (Muziol et al., 2006;
Bajorek et al., 2009; Xiao et al., 2009; Martinelli et al., 2012), their assembly into filaments must
involve interactions along an approximately longitudinal axis as previously envisioned for filaments and
tubes assembled in vitro (Lata et al., 2008; Henne et al., 2012; Dobro et al., 2013; Effantin et al.,
2013). Filament width varied from 4 to as much as 15 nm in both conical and flat spirals (Figure 3D),
excluding differences in accessibility to platinum deposition as a primary cause of the differences.
Instead, differences in platinum decoration are likely to reveal variations in molecular structure (Bachmann
et al., 1985). Wider filaments—sometimes with a split down their middle suggesting the presence
of parallel substrands—were most prevalent at the perimeter while thin filaments occurred throughout
but were almost always present near the spirals' center. Filaments sometimes abruptly changed width
(see examples highlighted in Figure 3A) further supporting the presence of subfilaments within wider
structures. Given the functional requirement for two ESCRT-III nucleating sites in ESCRT-II (Teis et al.,
2010) or Alix (Pires et al., 2009), one possibility is that parallel filaments create the outer turns of
a spiral but give way to single filaments with the potential for tighter curvature near the spiral's center.
The ability of specific ESCRT-III proteins to cap filament assembly (Teis et al., 2008) could promote
transition from wide to narrow filaments by ending one of two (or more) parallel filaments. Understanding
the functional significance and control of differences in filament content and shape will be an important question for the future.

Coassembly of CHMP4A with other ESCRT-III proteins creates
membrane-deforming filaments
We next wondered what it is about endogenous ESCRT-III filaments that promotes their assembly into
stereotyped membrane-deforming spirals. While deep-etch EM does not have the resolution to define
the arrangement of individual subunits, it allows us to compare filament shape and organization to that
of filaments assembled in transfected cells. We previously found that overexpressed FLAG-tagged
CHMP4 proteins create extensive networks of interconnected curved but flat filaments (Hanson et al.,
2008) and others have seen that CHMP4B and yeast Snf7 behave similarly in vitro (Pires et al., 2009;
Henne et al., 2012). To rule out any effects of the acidic FLAG-tag at the N-terminus of CHMP4A in our
earlier study (Hanson et al., 2008), we examined filaments formed by untagged CHMP4A (Figure 4A).
This was important because the FLAG-tag might specifically interfere with a recently described
N-terminal membrane insertion motif in CHMP4-family proteins (Buchkovich et al., 2013). As before,
CHMP4A filaments circle and spiral along the membrane to form an anastomosing network but do not
couple this to changes in membrane shape (Figure 4A). CHMP4A filaments also remain flat when built
from a constitutively ‘open’ CHMP4(α1–α5) truncation mutant (Shim et al., 2007; Figure 4B) or a K52E
mutant that enhances Snf7 assembly in yeast (Henne et al., 2012) (not shown). These consistently flat
networks indicate that interface(s) needed to deform the membrane are either not present or not
exposed in CHMP4 homopolymers even when intramolecular autoinhibitory contacts are released.
Given that ESCRT-III function in cellular events requires more than one ESCRT-III protein (Babst
et al., 2002; Morita et al., 2010, 2011), we hypothesized that coassembly of CHMP4 with additional
ESCRT-III proteins might be required to create filaments with the shape of the endogenous filaments
above. To test this idea, we examined the effect of coexpressing CHMP4A with CHMP2A based on the
fact that the ESCRT-III function in a wide variety of pathways and organisms requires members of both
the CHMP4 and CHMP2 subfamilies of proteins (Babst et al., 2002; Morita et al., 2010, 2011).
Previous biochemical analyses showed that full-length CHMP4A and CHMP2A do not efficiently
coassemble while heteropolymers form readily when either protein is activated by deleting its
autoinhibitory domain (Shim et al., 2007). Strikingly, membranes from cells co-expressing ‘open’
CHMP4A(α1–α5) and full-length CHMP2A were studded with eversions lined by spiraling filaments
(Figure 4C). Corresponding eversions were apparent protruding from the tops of whole cells (Figure 4D);
underlying filaments were revealed by delipidating fixed samples with detergent (Figure 4E). Similar
membrane-deforming filaments developed when we coexpressed full-length CHMP4A with ‘open’
CHMP2A(α1–α5) (not shown), demonstrating that the shape changes do not depend on C-terminal
autoinhibitory sequences in either protein. The fact that ESCRT-III heteropolymers differ from the sum
of their parts supports a model in which subunits such as CHMP2A coassemble with CHMP4 to change
the structure of the filament and its effects on membrane shape. Similar changes in filament morphology
were previously seen with purified proteins in vitro (Henne et al., 2012) suggesting that distinctive
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Figure 4. ESCRT-III polymer structure in transfected cells. Anaglyphs of plasma membranes from COS-7 cells
expressing (A) untagged CHMP4A, (B) CHMP4A(α1–α5), and (C–E) CHMP4A(α1–α5) and full-length CHMP2A
together. (C) Cytoplasmic surface of the plasma membrane from an unroofed cell with high magnification shown in
the inset, (D) corresponding top of a whole cell, and (E) top of a whole cell extracted with Triton X-100 and saponin
after fixation to expose the underlying protein scaffold. Use view glasses for 3D structure (left eye = red). Scale bars
represent 100 nm except in C where the scale bar on the survey view corresponds to 500 nm.
DOI: 10.7554/eLife.02184.007

heteropolymer shape may be a general feature of ESCRT-III biology. An important question for the
future will be to define how recruitment and assembly of appropriate ESCRT-III subunits is regulated
to create the requisite polymer shape.

ESCRT-III filaments surround nascent HIV-1 Gag assemblies
A challenge in thinking about the function of ESCRT-III spirals trapped by depleting Vps4 (Figures 2
and 3) is that they are typically not in contact with nascent or released vesicles. If spirals represent
‘scars’ left behind after vesicle budding, they have separated from the vesicles they helped to create.
An alternative possibility is that spirals represent the preferred arrangement of ESCRT-III when it
assembles spontaneously as a ‘blank’ in the absence of cargo (and Vps4). Efforts to see ESCRT-III
spirals on the surface of endosomes where their function in vesicle biogenesis is better defined were
complicated by poor retention and accessibility of these organelles to deep-etch EM as well as the
development of stacked class E compartments similar to those seen in Saccharomyces cerevisiae
(Nickerson et al., 2006, and not shown). We therefore turned to the best-characterized ESCRTdependent event at the plasma membrane, Human Immunodeficiency Virus (HIV-1) budding. HIV-1
assembly is driven by polymerization of the virally encoded Gag polyprotein, which recruits cellular
ESCRT proteins to facilitate virion release from the plasma membrane and can be expressed alone to
produce virus-like particles (VLPs) (Gheysen et al., 1989; Karacostas et al., 1989; Sundquist and
Krausslich, 2012). Current thinking based on electron tomography of immature virions (Wright et al.,
2007; Carlson et al., 2008; Briggs et al., 2009) and bud sites (Carlson et al., 2008) is that ESCRTs
and especially ESCRT-III play important roles both in completing the viral sphere (that is only 2/3 covered
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by polymerized Gag) and in severing its connection to the cell. ESCRT-III and Vps4 are transiently
recruited to Gag assemblies to mediate release (Jouvenet et al., 2011). This machinery is typically
thought to act on the cytoplasmic surface of the plasma membrane to constrict the vesicle neck and
release a viral particle (Sundquist and Krausslich, 2012), although a recent study using fluorescently
labeled proteins and superresolution imaging raised the possibility of similar constriction from within
the viral particle (Van Engelenburg et al., 2014). Using deep-etch EM allows us to capture snapshots
of this process while assessing the relationship between ESCRT-III and HIV-1 Gag as a readily recognizable cargo.
HEK293T cells transiently expressing HIV-1 Gag (Figure 5) or Gag-GFP (Figure 5—figure supplement 1)
produce abundant VLPs that are readily apparent by deep-etch EM both on and around cells as well
as beneath unroofed plasma membranes (Figure 5A–C). Release of VLPs was corroborated by fluorescence microscopy of cells expressing Gag-GFP (Figure 5—figure supplement 1) and by isolation and
immunoblotting of VLPs (not shown). Unroofed plasma membranes display unique circular and semispherical protein assemblies ranging in size up to the diameter of VLPs that appear to be nascent Gag
assemblies (Figure 5D). In order to ascertain that these in fact contain Gag, we immunodecorated
unroofed cells with an antibody specific to the membrane-proximal matrix (MA) domain of Gag
(Figure 5E–H). Gold particles were numerous around putative Gag assemblies on unroofed plasma

Figure 5. Deep-etch EM of HIV-1 VLP budding. (A) Low magnification view of an unroofed HIV-1 Gag-transfected
HEK293T cell surrounded by VLPs. (B) Top view of whole cell budding VLPs. (C) View of unroofed plasma membrane
showing bumps corresponding to VLPs trapped underneath the membrane. (D) Views of unroofed plasma membrane
showing Gag assemblies exposed on the cytoplasmic surface of the plasma membrane. (E–H) Immunodecoration of
Gag on detergent extracted plasma membranes (E and E′), detergent extracted VLPs (F and F′), intact unroofed
plasma membranes (G and G′) and intact VLPs (H). (E′, F′ and G′ are same as E, F and G but show gold in yellow).
Use view glasses for 3D structure (left eye = red). Scale bars represent (A) 500 nm, (B–H) 100 nm.
DOI: 10.7554/eLife.02184.008
The following figure supplements are available for figure 5:
Figure supplement 1. VLP formation by HIV-1 Gag-GFP.
DOI: 10.7554/eLife.02184.009
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membranes (Figure 5E,E′) and around VLPs (Figure 5F,F′) when samples were delipidated by detergent
extraction after fixation. When membranes were intact, immunodecoration of Gag assemblies was
limited to their perimeter (Figure 5G,G′) and was abolished in released VLPs (Figure 5H) as expected.
By deep-etch EM, Gag-GFP assemblies were less uniform in size and shape than those containing Gag
(Figure 5—figure supplement 1C), consistent with the irregular distribution of Gag-GFP seen by thin
section EM (Pornillos et al., 2003) and with the decreased Gag content of VLPs containing Gag fused
to similarly sized fluorescent proteins (Gunzenhauser et al., 2012). Notably there was no evidence
by direct viewing or immunolabeling (not shown) to indicate the presence of ESCRT-III on or near any
of these Gag assemblies. This is not surprising given live cell studies showing that ESCRT-III and Vps4
are only transiently recruited after Gag assembly is essentially complete (Baumgartel et al., 2011;
Jouvenet et al., 2011).
To explore the role of ESCRT-III filaments in VLP biogenesis, we therefore once again depleted cells
of Vps4 to stabilize ESCRT-III in its assembled state. As expected, expressing a dominant negative
mutant of Vps4A (Vps4A E228Q) or silencing Vps4 as above increased the amount of Gag-GFP
(Figure 6—figure supplement 1A) or Gag (Figure 6—figure supplement 1B) on the plasma membrane and decreased release of VLPs as detected by particle analysis methods (data not shown).
Strikingly, in cells lacking Vps4 Gag assemblies on the plasma membrane were now often surrounded
by a single filament not seen in control cells (Figure 6). The encircling filaments appeared similar to the
ESCRT-III filaments examined above, each ranging from 4.5–12.8 nm (average 8.6 ± 1.6 nm, n = 96) in
width with the majority wide enough to contain more than one ∼4 nm substrand. Immunolabeling
confirmed that ESCRT-III proteins localized to the perimeter of Gag assemblies coincident with the filaments (Figure 6D). Interestingly, the encircling filaments surrounded Gag assemblies of various sizes
ranging from ∼60–150 nm suggesting that the threshold amount of Gag needed to activate ESCRT-III
assembly may be decreased in the setting of reduced Vps4 leading to premature nucleation of the
ESCRT-III ring. Alternatively, these smaller Gag assemblies may indicate a role for ESCRT-III filaments
in confining Gag (or other cargo proteins) in a domain that normally expands upon remodeling by
Vps4. More deeply invaginated Gag assemblies were sometimes surrounded by what appeared to be
tightly spiraled ESCRT-III filaments, and immunolabeling confirmed that ESCRT-III was present on the
cytoplasmic rim and surrounding surface of these invaginating VLPs (Figure 6D, right panel and not
shown). These spirals may correspond to the darkly stained ring previously noted in thin section EM
analysis of HIV-1 budding from cells depleted of CHMP2A (and therefore unable to engage Vps4)
(Morita et al., 2011) and seem likely to represent trapped intermediates in the biogenesis of VLPs.
How do Gag assemblies recruit ESCRT-III filaments? We noticed that ESCRT-III filaments (in cells
depleted of Vps4) were frequently connected to the central Gag assembly by perpendicular ‘struts’
∼14 nm long (Figure 6, see green highlighting in inset). These struts resemble previous negative stain
images of purified Alix bound perpendicularly to Snf7 filaments (Pires et al., 2009) although based on
size they could also correspond to ESCRT-I (Boura et al., 2011), an ESCRT-I-ESCRT-II supercomplex
(Boura et al., 2012), or something else altogether. The C-terminal p6 domain of Gag contains a PTAP
motif (essential for interaction with the ESCRT-I protein Tsg101 [Garrus et al., 2001]) and a LYPXnL
motif (involved in interaction with ALIX [Strack et al., 2003]) and has been shown to be essential for
budding of Gag VLPs as well as HIV-1. To determine whether these motifs are required for ESCRT-III
recruitment, we deleted the p6 domain from Gag (referred to as GagΔp6). In cells expressing GagΔp6,
very few VLPs were released and instead large numbers of arrested Gag-containing buds accumulated
on the surface (Figure 7 and not shown). Importantly, this was true regardless of whether Vps4 was
present or not, confirming that the p6 domain is required for VLP release. On unroofed plasma
membranes Gag assemblies similar to those formed by full-length Gag were observed but were not
surrounded by ESCRT-III rings (Figure 7), demonstrating that p6 sequences are required to recruit
ESCRT-III. Furthermore, no struts were apparent, consistent with the hypothesis that these correspond
to ESCRT-I and/or Alix. We were, however, unable to confirm the identity of the struts because available antibodies were unsuitable. Detailed mutagenesis coupled with antibodies appropriate for immunodecoration on these samples will be needed to conclusively identify these structures.

Models for ESCRT-III function in vesicle biogenesis
The data presented here provide the first views of endogenous ESCRT-III filaments forming the rings
and spirals frequently drawn in models of ESCRT function but not previously seen on cellular membranes. Earlier studies of various ESCRT-III polymers in vitro and in transfected cells inspired thinking
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Figure 6. ESCRT-III filaments surround Gag assemblies in cells depleted of Vps4. (A) HEK293T cells treated with
Vps4A & Vps4B siRNA accumulate unique filament-encircled Gag assemblies. Inset is pseudo-colored to show the
central Gag assembly (blue), surrounding filament (red), and perpendicular ‘struts’ between them (green). Each field
also shows the occasionally seen subplasmalemmal VLP bump to provide a sense of scale. (B) Individual views of
Gag assemblies, (C) Gag-GFP assemblies, and (D) Gag assemblies immunodecorated with indicated gold conjugated
antibodies. Scale bars represent 100 nm. Each box in B–D is a 320 nm square. Use view glasses for 3D structure
(left eye = red).
DOI: 10.7554/eLife.02184.010
The following figure supplements are available for figure 6:
Figure supplement 1. VLP release is impaired by inactivating or depleting Vps4.
DOI: 10.7554/eLife.02184.011

about how different filamentous and tubular structures might function in vesicle biogenesis and
membrane scission. Ideas ranged from purse-string like constriction of a ring (Saksena et al., 2009) to
polymer-driven membrane buckling (Lenz et al., 2009) to the more prevalent dome-based membrane
scission model (Fabrikant et al., 2009) and its variants (Boura et al., 2012; Elia et al., 2012; Henne
et al., 2012). We propose a modified model that builds on many of these previous ideas, interpolating
between the rings of ESCRT-III we see around HIV-1 Gag assemblies and the completed conical spirals
that accumulate on the membrane (Figure 8). In this model, a first role for ESCRT-III is to encircle
and thereby delineate cargo and membrane destined for inclusion in a vesicle or VLP (Figure 8A).
The encircling filament develops when nucleating factors activated by cargo form struts around a
central domain and in turn recruit ESCRT-III. Either because of intrinsic filament curvature or because
of multiple contacts with cargo, ESCRT-III filaments grow to surround the cargo (Figure 8A). Because
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encircled Gag assemblies uniquely accumulate
when Vps4 is missing (Figure 6), we propose that
an important and previously unappreciated role
for Vps4 is to release connection(s) between the
ESCRT-III filament and cargo, perhaps displacing
the struts while also opening the ring. The ESCRTIII filament can then grow to adopt its preferred
shape as a conical spiral (Figure 8B) potentially
driving neck constriction and vesicle release as
shown (Figure 8C). Finally (and not shown), Vps4
is also responsible for disassembling ESCRT-III
filaments to recycle their subunits during or after
vesicle release.
While this model remains speculative because
it is based on static images of ESCRT-III polymers
stabilized by depleting Vps4, it both supports
important aspects of earlier models describing
ESCRT-III driven membrane remodeling (Fabrikant
et al., 2009; Wollert et al., 2009; Elia et al.,
2012; Henne et al., 2012) and provides explanations for a few previously enigmatic observations. Interestingly, there are similarities between
the different forms of ESCRT-III seen here and
structures previously described by EM of purified
Figure 7. Deep-etch EM of Gag budding without
yeast proteins (Henne et al., 2012). Specifically,
its ESCRT-recruiting p6 domain. (A) Top surface of
HEK293T cell expressing GagΔp6 showing blocked VLP
Henne et al. found that combining ESCRT-II as a
budding. (B) Top surface of Vps4-depleted HEK293T
nucleating factor with ESCRT-III proteins (Vps20
cell expressing GagΔp6 showing similar blocked VLP
and Snf7 or a combination of four core ESCRT-III
budding. (C) Unroofed plasma membrane correspondproteins) generated rings of ESCRT-III ∼50–70 nm
ing to A. (D) Unroofed plasma membrane correspondin diameter, appropriate for surrounding a domain
ing to B. Note the invaginated Gag assemblies with
needed to create 25–35 nm ILVs characteristic of
no surrounding ESCRT-III ring (C and D). C′ and D′ are
yeast MVBs. In our images, the ∼110 nm average
identical to C and D but with Gag assemblies colored
outer diameter (Figure 3C) of ESCRT-III spirals
yellow for clarity. Scale bar represents 100 nm. Use view
would in an analogous manner support formation
glasses for 3D structure (left eye = red).
of the ∼50 nm vesicles typical of mammalian ILVs
DOI: 10.7554/eLife.02184.012
and extracellular vesicles. Henne et al. also found
that combining ESCRT-III proteins with each other
in the absence of ESCRT-II created spring-like three-dimensional coils. Not clear was whether (and
how) rings might convert into spiraling filaments. We suggest that Vps4 may have a general role in
converting a cargo confining ring to a vesicle-generating spiral, likely by separating ESCRT-III from
nucleating factors seen as struts in our model. The idea that Vps4 plays specific and essential roles
both before and after membrane scission is supported by a number of observations. Fluorescently
tagged Vps4 is recruited to growing viral particles before they are released (Baumgartel et al., 2011;
Jouvenet et al., 2011), Vps4 appears at two stages prior to cellular abscission (Elia et al., 2011),
ESCRT-III and Vps4 are recruited simultaneously to the centroid of dividing Crenarchaea (Samson
et al., 2011), and perturbing Vps4 function and/or regulation changes ILV size and/or release in yeast
(Nickerson et al., 2010; Wemmer et al., 2011; Adell et al., 2014).
A prediction of our model is that interfering with Vps4 activity—whether by depleting it or expressing a dominant negative mutant—will trap ESCRT-III around the base of incipient vesicular structures
and in particular around the base of emerging Gag assemblies. This trapped ESCRT-III will remain
attached to Gag inside any VLPs that are ultimately released. This in turn will increase ESCRT-III recovered in whatever VLPs are released, something that we (data not shown) and others (Van Engelenburg
et al., 2014) have in fact observed.
While we favor the model shown in Figure 8, one can also envision other ways in which the remodeling of ESCRT-III rings and spirals could contribute to vesicle formation and membrane scission.
Future coupling of the ability to see membrane-bound ESCRT assemblies using deep-etch EM with
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techniques capable of resolving and potentially
controlling protein and membrane dynamics will
be important in gaining new insight into these
processes. Defining the detailed temporal relationship between Vps4 activity and ESCRT-III
assembly during virus or vesicle formation will be
particularly important. Additionally, while we have
taken advantage of the fact that ESCRT polymers
are present on the plasma membrane to facilitate
deep-etch EM imaging, future studies of their
function at the plasma membrane are clearly warranted. Overall, the work described here establishes that endogenous ESCRT-III takes the form of
filaments that form circles and conical spirals on
the membrane. We propose that these rings and
spirals, while longer-lived than normal, represent
functional states of a general ESCRT-III membrane
scission machine.

Materials and methods
Cell culture
Figure 8. Speculative model describing ESCRT-III
and Vps4 function in vesicle biogenesis and release.
(A) Cargo - loosely defined to include either HIV-1 Gag
or material destined for incorporation into ILVs–is
concentrated in the circular domain shown in pink.
After reaching some threshold, cargo recruits and/or
activates factors to initiate ESCRT-III assembly. These
are represented here by green ‘struts’ perpendicular
to the cargo perimeter. Once nucleated, the ESCRT-III
filament extends to surround and confine cargo.
In the absence of Vps4, this intermediate accumulates.
(B) When present, we propose a new role for Vps4 in
which it is engaged to break connection(s) between
ESCRT-III and cargo, thereby allowing the ESCRT-III
spiral to grow into its preferred spiral shape. ESCRT-III
recruits new membrane into the neck as it grows, shown
by the addition of blue membrane to the budding
vesicle. (C) A fully assembled ESCRT-III spiral narrows
the membrane neck, ultimately driving vesicle release.
DOI: 10.7554/eLife.02184.013

HeLa, HEK293T, U2OS, and COS-7 cells originally
derived from ATCC were grown in DME (Invitrogen,
Grand Island, NY) containing 10% fetal bovine
serum (Atlanta Biologics, Atlanta GA) and 2 mM
L-glutamine.

Plasmids and antibodies

pCMV55 encoding HIV-1 Gag was kindly provided
by Dr Lee Ratner (Washington University, St. Louis
MO) and used as previously described (Shim
et al., 2007). The p6 domain of Gag was deleted
by introducing a stop codon to remove 52 amino
acids from the C-terminus and introduce an XhoI
site using the primer AAAAAACTCGAGTTAAAAA
TTCCCTGGCCTTCCCTTG.
Full length and p6 deleted Gag were cloned
into pcDNA4TO (Invitrogen). pGag-EGFP was
obtained through the NIH AIDS Reagent Program,
Division of AIDS, NIAID, NIH (Cat#11468) from
Dr Marilyn Resh (Hermida-Matsumoto and Resh,
2000). Plasmids encoding ESCRT-III proteins have
been previously described, including untagged
human CHMP4A (also referred to as hSnf7-1) in pcDNA3 (Lin et al., 2005), CHMP4A(α1–α5) in
pcDNA3.1FLAG (Shim et al., 2007), and CHMP2A full length and α1–α5 truncation in pcDNA3.1FLAG
(Shim et al., 2007).
Antibodies used include rabbit polyclonals against Gag (MA-specific; kind gift from Dr Lee Ratner,
Washington University School of Medicine, St. Louis MO), CHMP6 (PA5-21831; ThermoScientific,
Waltham MA), CHMP4A (Lin et al., 2005), CHMP4B (Shiels et al., 2007), CHMP2A (sc67227; Santa
Cruz, Dallas, TX), CHMP2B (ab33174; AbCam, Cambridge, England), CHMP1B (14639-1-AP; Protein
Tech Group, Chicago, IL), VPS4B (Lin et al., 2005) and mouse monoclonals against tubulin (Sigma,
St. Louis MO) and α-SNAP (SySy, Gottingen, Germany).
siRNA duplexes targeting VPS4A (CCGAGAAGCUGAAGGAUUAdTdT) and VPS4B (CCAAAGA
AGCACUGAAAGAdTdT) have been previously described (Kieffer et al., 2008) and were from
ThermoScientific.
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Polymer sedimentation analysis
Detergent solubility assays to monitor ESCRT-III polymer assembly after Vps4 depletion were as
previously described (Shim et al., 2007).

Immunofluorescence
HeLa and HEK293T cells plated on glass coverslips were stained as previously described (Shim et al.,
2007). Confocal imaging was performed on an Olympus FV500 or FV1200 microscope using a 60x 1.4
NA objective. Maximum intensity projections were prepared using ImageJ (version 1.47u). Brightness
and contrast were adjusted as necessary with Adobe Photoshop (Adobe Systems, San Jose, CA) and
composite figures were prepared in Adobe Illustrator.

Transfections and sample preparation for deep-etch EM
Cells plated at ∼70% confluence were transfected with 15 nM each of siRNA duplexes targeting VPS4A
and VPS4B using Dharmafect#1 according to manufacturer guidelines. Cells were trypsinized ∼24 hr
later and replated onto 12 mm poly-L- or poly-D-lysine coated BioCoat coverslips (BD Biosciences,
East Rutherford NJ). Plasma membranes were prepared the following day, typically 40–50 hr after initial siRNA transfection. This was done as previously described (Hanson et al., 2008). Briefly, coverslips
were washed in 30 mM Hepes, pH 7.4, 100 mM NaCl, 2 mM CaCl2 and then dipped into an intracellular buffer (30 mM Hepes, pH 7.2, 70 mM KCl, 5 mM MgCl2, and 3 mM EGTA) and subjected to a
brief pulse of ultrasound before transfer into the same buffer containing fixative (2% glutaraldehyde or
2% PFA if immunostaining was planned). The area of coverslip with the highest yield of plasma membranes was identified by phase contrast microscopy and trimmed with a diamond knife to ∼3 × 3 mm.
Transfection of Gag or Gag-GFP encoding plasmids was performed using Lipofectamine 2000 (Life
Technologies, Grand Island, NY) according to the manufacturer's instructions. When combined with
siRNA transfections, plasmid transfections were carried out 24 hr after initial introduction of siRNA.
ESCRT-III encoding plasmids were transfected as previously described (Hanson et al., 2008) again using
Lipofectamine 2000 (Life Technologies). To extract fixed samples with detergent (Figures 4E, 5E,F),
fixed coverslips were incubated for 2 hr in buffer containing 1% Triton X-100 and 0.1% saponin.

Immunogold antibody decoration
Antibody staining was performed as previously described (Hanson et al., 2008) using 18 nm goldconjugated goat anti-rabbit or anti-mouse (Jackson Immunoresearch, West Grove, PA) antibodies.

Freezing, replicating, and imaging deep-etch samples
Samples were prepared essentially as described (Hanson et al., 2008) except that platinum (∼2 nm, as
before) was evaporated onto samples from 17–18° above the horizontal. Replicas were viewed on a
JEOL 1400 transmission electron microscope at two different tilt angles (either ±5 or ±10°) and images
were captured using an AMT camera. Digital image pairs were made into anaglyphs by converting one
each to red and blue/green, layering them on top of each other using the screen blending mode in
Adobe Photoshop, and finally aligning them to each other using the auto-align function. Composite
figures were prepared using Adobe Illustrator. Digital measurements were made using ImageJ (v. 1.47u).

Acknowledgements
We thank members of the Hanson laboratory and our colleagues at Washington University for helpful
discussions and Erin Blumer for help drawing the model in Figure 8. This work was supported by R01
GM076686 from the National Institutes of Health to PIH.

Additional information
Funding
Funder

Grant reference number

Author

National Institutes of
Health

R01 GM076686

Anil G Cashikar,
Soomin Shim, Robyn Roth,
Michael R Maldazys,
Phyllis I Hanson

The funders had no role in study design, data collection and interpretation, or the decision
to submit the work for publication.

Cashikar et al. eLife 2014;3:e02184. DOI: 10.7554/eLife.02184

14 of 17

Research article

Cell biology

Author contributions
AGC, PIH, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting
or revising the article; SS, RR, JEH, Conception and design, Acquisition of data, Analysis and interpretation of data; MRM, Acquisition of data, Analysis and interpretation of data

References

Adell MAY, Vogel GF, Pakdel M, Müller M, Lindner H, Hess MW, Teis D. 2014. Coordinated binding of Vps4 to
ESCRT-III drives membrane neck constriction during MVB vesicle formation. The Journal of Cell Biology
205:33–49. doi: 10.1083/jcb.201310114.
Babst M, Katzmann DJ, Estepa-Sabal EJ, Meerloo T, Emr SD. 2002. Escrt-III: an endosome-associated heterooligomeric
protein complex required for mvb sorting. Developmental Cell 3:271–282. doi: 10.1016/S1534-5807(02)00220-4.
Babst M, Katzmann D, Snyder WB, Wendland B, Emr SD. 2002. Endosome-associated complex, ESCRT-II, recruits
transport machinery for protein sorting at the multivesicular body. Developmental Cell 3:283–289. doi: 10.1016/
S1534-5807(02)00219-8.
Babst M, Wendland B, Estepa EJ, Emr SD. 1998. The Vps4p AAA ATPase regulates membrane association of a
Vps protein complex required for normal endosome function. The EMBO Journal 17:2982–2993. doi: 10.1093/
emboj/17.11.2982.
Bachmann L, Becker R, Leupold G, Barth M, Guckenberger R, Baumeister W. 1985. Decoration and shadowing of
freeze-etched catalase crystals. Ultramicroscopy 16:305–320. doi: 10.1016/0304-3991(85)90099-3.
Bajorek M, Schubert HL, McCullough J, Langelier C, Eckert DM, Stubblefield WM, Uter NT, Myszka DG, Hill CP,
Sundquist WI. 2009. Structural basis for ESCRT-III protein autoinhibition. Nature Structural & Molecular Biology
16:754–762. doi: 10.1038/nsmb.1621.
Baumgartel V, Ivanchenko S, Dupont A, Sergeev M, Wiseman PW, Krausslich HG, Brauchle C, Muller B, Lamb DC.
2011. Live-cell visualization of dynamics of HIV budding site interactions with an ESCRT component. Nature Cell
Biology 13:469–474. doi: 10.1038/ncb2215.
Bodon G, Chassefeyre R, Pernet-Gallay K, Martinelli N, Effantin G, Hulsik DL, Belly A, Goldberg Y,
Chatellard-Causse C, Blot B, Schoehn G, Weissenhorn W, Sadoul R. 2011. Charged multivesicular body protein
2B (CHMP2B) of the endosomal sorting complex required for transport-III (ESCRT-III) polymerizes into
helical structures deforming the plasma membrane. The Journal of Biological Chemistry 286:40276–40286.
doi: 10.1074/jbc.M111.283671.
Boura E, Rózycki B, Chung H, Herrick D, Canagarajah B, Cafiso D, Eaton W, Hummer G, Hurley J. 2012. Solution
structure of the ESCRT-I and -II supercomplex: implications for membrane budding and scission. Structure
20:874–886. doi: 10.1016/j.str.2012.03.008.
Boura E, Różycki B, Herrick DZ, Chung HS, Vecer J, Eaton WA, Cafiso DS, Hummer G, Hurley JH. 2011.
Solution structure of the ESCRT-I complex by small-angle X-ray scattering, EPR, and FRET spectroscopy.
Proceedings of the National Academy of Sciences of the United States of America 108:9437–9442.
doi: 10.1073/pnas.1101763108.
Briggs JAG, Riches JD, Glass B, Bartonova V, Zanetti G, Kräusslich H-G. 2009. Structure and assembly of immature
HIV. Proceedings of the National Academy of Sciences of the United States of America 106:11090–11095.
doi: 10.1073/pnas.0903535106.
Buchkovich NJ, Henne WM, Tang S, Emr SD. 2013. Essential n-terminal insertion motif anchors the ESCRT-III
filament during MVB vesicle formation. Developmental Cell 27:201–214. doi: 10.1016/j.devcel.2013.09.009.
Carlson LA, Briggs JA, Glass B, Riches JD, Simon MN, Johnson MC, Muller B, Grunewald K, Krausslich HG. 2008.
Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis.
Cell Host & Microbe 4:592–599. doi: 10.1016/j.chom.2008.10.013.
Choudhuri K, Llodrá J, Roth EW, Tsai J, Gordo S, Wucherpfennig KW, Kam LC, Stokes DL, Dustin ML. 2014.
Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse. Nature 507:118–123.
doi: 10.1038/nature12951.
Davies BA, Azmi IF, Payne J, Shestakova A, Horazdovsky BF, Babst M, Katzmann DJ. 2010. Coordination of
substrate binding and ATP hydrolysis in Vps4-mediated ESCRT-III disassembly. Molecular Biology of the Cell
21:3396–3408. doi: 10.1091/mbc.E10-06-0512.
Dobro MJ, Samson RY, Yu Z, McCullough J, Ding HJ, Chong PL-G, Bell SD, Jensen GJ. 2013. Electron
cryotomography of ESCRT assemblies and dividing Sulfolobus cells suggest spiraling filaments are involved in
membrane scission. Molecular Biology of the Cell 24:2319–2327. doi: 10.1091/mbc.E12-11-0785.
Effantin G, Dordor A, Sandrin V, Martinelli N, Sundquist WI, Schoehn G, Weissenhorn W. 2013. ESCRT-III
CHMP2A and CHMP3 form variable helical polymers in vitro and act synergistically during HIV-1 budding.
Cellular Microbiology 15:213–226. doi: 10.1111/cmi.12041.
Elia N, Fabrikant G, Kozlov MM, Lippincott-Schwartz J. 2012. Computational model of cytokinetic abscission
driven by ESCRT-III polymerization and remodeling. Biophysical Journal 102:2309–2320. doi: 10.1016/j.
bpj.2012.04.007.
Elia N, Sougrat R, Spurlin TA, Hurley JH, Lippincott-Schwartz J. 2011. Dynamics of endosomal sorting complex
required for transport (ESCRT) machinery during cytokinesis and its role in abscission. Proceedings of the
National Academy of Sciences of the United States of America 108:4846–4851. doi: 10.1073/pnas.1102714108.
Fabbro M, Zhou BB, Takahashi M, Sarcevic B, Lal P, Graham ME, Gabrielli BG, Robinson PJ, Nigg EA, Ono Y,
Khanna KK. 2005. Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is

Cashikar et al. eLife 2014;3:e02184. DOI: 10.7554/eLife.02184

15 of 17

Research article

Cell biology
required for its recruitment to midbody and cytokinesis. Developmental Cell 9:477–488. doi: 10.1016/j.
devcel.2005.09.003.
Fabrikant G, Lata S, Riches JD, Briggs JA, Weissenhorn W, Kozlov MM. 2009. Computational model of membrane
fission catalyzed by ESCRT-III. PLOS Computational Biology 5:e1000575. doi: 10.1371/journal.pcbi.1000575.
Fyfe I, Schuh AL, Edwardson JM, Audhya A. 2011. Association of the endosomal sorting complex ESCRT-II with
the Vps20 subunit of ESCRT-III generates a curvature-sensitive complex capable of nucleating ESCRT-III
filaments. The Journal of Biological Chemistry 286:34262–34270. doi: 10.1074/jbc.M111.266411.
Garrus JE, von Schwedler UK, Pornillos O, Morham SG, Kavitz KH, Wang HE, Wettstein DA, Stray KM, Cote MH,
Rich RL, Myszka DG, Sundquist WI. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for
HIV-1 budding. Cell 107:55–65. doi: 10.1016/S0092-8674(01)00506-2.
Ghazi-Tabatabai S, Saksena S, Short JM, Pobbati AV, Veprintsev DB, Crowther RA, Emr SD, Egelman EH, Williams RL.
2008. Structure and disassembly of filaments formed by the ESCRT-III subunit Vps24. Structure 16:1345–1356.
doi: 10.1016/j.str.2008.06.010.
Gheysen D, Jacobs E, de Foresta F, Thiriart C, Francotte M, Thines D, De Wilde M. 1989. Assembly and release
of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103–112.
doi: 10.1016/0092-8674(89)90873-8.
Guizetti J, Schermelleh L, Mantler J, Maar S, Poser I, Leonhardt H, Muller-Reichert T, Gerlich DW. 2011.
Cortical constriction during abscission involves helices of ESCRT-III-dependent filaments. Science
331:1616–1620. doi: 10.1126/science.1201847.
Gunzenhauser J, Olivier N, Pengo T, Manley S. 2012. Quantitative super-resolution imaging reveals protein
stoichiometry and nanoscale morphology of assembling HIV-Gag virions. Nano Letters 12:4705–4710.
doi: 10.1021/nl3021076.
Hanson PI, Cashikar A. 2012. Multivesicular body morphogenesis. Annual Review of Cell and Developmental
Biology 28:337–362. doi: 10.1146/annurev-cellbio-092910-154152.
Hanson PI, Roth R, Lin Y, Heuser JE. 2008. Plasma membrane deformation by circular arrays of ESCRT-III protein
filaments. The Journal of Cell Biology 180:389–402. doi: 10.1083/jcb.200707031.
Henne WM, Buchkovich NJ, Zhao Y, Emr SD. 2012. The endosomal sorting complex ESCRT-II mediates the assembly
and architecture of ESCRT-III helices. Cell 151:356–371. doi: 10.1016/j.cell.2012.08.039.
Henne WM, Stenmark H, Emr SD. 2013. Molecular mechanisms of the membrane sculpting ESCRT pathway.
Cold Spring Harbor Perspectives in Biology 5:a016766. doi: 10.1101/cshperspect.a016766.
Hermida-Matsumoto L, Resh MD. 2000. Localization of human immunodeficiency virus type 1 Gag and Env at the
plasma membrane by confocal imaging. Journal of Virology 74:8670–8679. doi: 10.1128/JVI.74.18.8670-8679.2000.
Heuser J. 2000. The production of ‘cell cortices’ for light and electron microscopy. Traffic 1:545–552.
doi: 10.1034/j.1600-0854.2000.010704.x.
Hurley JH. 2010. The ESCRT complexes. Critical Reviews in Biochemistry and Molecular Biology 45:463–487.
doi: 10.3109/10409238.2010.502516.
Jimenez AJ, Maiuri P, Lafaurie-Janvore J, Divoux S, Piel M, Perez F. 2014. ESCRT machinery is required for plasma
membrane repair. Science 343:1247136. doi: 10.1126/science.1247136.
Jouvenet N, Zhadina M, Bieniasz PD, Simon SM. 2011. Dynamics of ESCRT protein recruitment during retroviral
assembly. Nature Cell Biology 13:394–401. doi: 10.1038/ncb2207.
Karacostas V, Nagashima K, Gonda MA, Moss B. 1989. Human immunodeficiency virus-like particles produced
by a vaccinia virus expression vector. Proceedings of the National Academy of Sciences of the United States of
America 86:8964–8967. doi: 10.1073/pnas.86.22.8964.
Kieffer C, Skalicky JJ, Morita E, De Domenico I, Ward DM, Kaplan J, Sundquist WI. 2008. Two distinct modes
of ESCRT-III recognition are required for VPS4 functions in lysosomal protein targeting and HIV-1 budding.
Developmental Cell 15:62–73. doi: 10.1016/j.devcel.2008.05.014.
Lata S, Schoehn G, Jain A, Pires R, Piehler J, Gottlinger HG, Weissenhorn W. 2008. Helical structures of ESCRT-III
are disassembled by VPS4. Science 321:1354–1357. doi: 10.1126/science.1161070.
Lenz M, Crow D, Joanny J-F. 2009. Membrane buckling induced by curved filaments. Physical Review Letters
103:038101. doi: 10.1103/PhysRevLett.103.038101.
Lin Y, Kimpler LA, Naismith TV, Lauer JM, Hanson PI. 2005. Interaction of the mammalian endosomal sorting
complex required for transport (ESCRT) III protein hSnf7-1 with itself, membranes, and the AAA+ ATPase SKD1.
The Journal of Biological Chemistry 280:12799–12809. doi: 10.1074/jbc.M413968200.
Martinelli N, Hartlieb B, Usami Y, Sabin C, Dordor A, Miguet N, Avilov SV, Ribeiro EAJ, Gottlinger H, Weissenhorn W.
2012. CC2D1A Is a regulator of ESCRT-III CHMP4B. Journal of Molecular Biology 419:75–88. doi: 10.1016/j.
jmb.2012.02.044.
McCullough J, Colf LA, Sundquist WI. 2013. Membrane fission reactions of the mammalian ESCRT pathway.
Annual Review of Biochemistry 82:663–692. doi: 10.1146/annurev-biochem-072909-101058.
Morita E, Colf LA, Karren MA, Sandrin V, Rodesch CK, Sundquist WI. 2010. Human ESCRT-III and VPS4 proteins
are required for centrosome and spindle maintenance. Proceedings of the National Academy of Sciences of the
United States of America 107:12889–12894. doi: 10.1073/pnas.1005938107.
Morita E, Sandrin V, McCullough J, Katsuyama A, Baci Hamilton I, Sundquist WI. 2011. ESCRT-III protein
requirements for HIV-1 budding. Cell Host & Microbe 9:235–242. doi: 10.1016/j.chom.2011.02.004.
Murk JLAN, Humbel BM, Ziese U, Griffith JM, Posthuma G, Slot JW, Koster AJ, Verkleij AJ, Geuze HJ,
Kleijmeer MJ. 2003. Endosomal compartmentalization in three dimensions: implications for membrane
fusion. Proceedings of the National Academy of Sciences of the United States of America 100:13332–13337.
doi: 10.1073/pnas.2232379100.

Cashikar et al. eLife 2014;3:e02184. DOI: 10.7554/eLife.02184

16 of 17

Research article

Cell biology
Muziol T, Pineda-Molina E, Ravelli RB, Zamborlini A, Usami Y, Gottlinger H, Weissenhorn W. 2006. Structural basis
for budding by the ESCRT-III factor CHMP3. Developmental Cell 10:821–830. doi: 10.1016/j.devcel.2006.03.013.
Nabhan JF, Hu R, Oh RS, Cohen SN, Lu Q. 2012. Formation and release of arrestin domain-containing
protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein.
Proceedings of the National Academy of Sciences of the United States of America 109:4146–4151.
doi: 10.1073/pnas.1200448109.
Nickerson DP, West M, Henry R, Odorizzi G. 2010. Regulators of Vps4 ATPase activity at endosomes differentially
influence the size and rate of formation of intralumenal vesicles. Molecular Biology of the Cell 21:1023–1032.
doi: 10.1091/mbc.E09-09-0776.
Nickerson DP, West M, Odorizzi G. 2006. Did2 coordinates Vps4-mediated dissociation of ESCRT-III from
endosomes. The Journal of Cell Biology 175:715–720. doi: 10.1083/jcb.200606113.
Peel S, Macheboeuf P, Martinelli N, Weissenhorn W. 2011. Divergent pathways lead to ESCRT-III-catalyzed
membrane fission. Trends in Biochemical Sciences 36:199–210. doi: 10.1016/j.tibs.2010.09.004.
Pires R, Hartlieb B, Signor L, Schoehn G, Lata S, Roessle M, Moriscot C, Popov S, Hinz A, Jamin M, Boyer V,
Sadoul R, Forest E, Svergun DI, Gottlinger HG, Weissenhorn W. 2009. A crescent-shaped ALIX dimer targets
ESCRT-III CHMP4 filaments. Structure 17:843–856. doi: 10.1016/j.str.2009.04.007.
Pornillos O, Higginson DS, Stray KM, Fisher RD, Garrus JE, Payne M, He GP, Wang HE, Morham SG, Sundquist WI.
2003. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. The Journal of Cell Biology
162:425–434. doi: 10.1083/jcb.200302138.
Saksena S, Wahlman J, Teis D, Johnson AE, Emr SD. 2009. Functional reconstitution of ESCRT-III assembly and
disassembly. Cell 136:97–109. doi: 10.1016/j.cell.2008.11.013.
Samson RY, Obita T, Hodgson B, Shaw MK, Chong PL, Williams RL, Bell SD. 2011. Molecular and structural basis
of ESCRT-III recruitment to membranes during archaeal cell division. Molecular Cell 41:186–196. doi: 10.1016/j.
molcel.2010.12.018.
Shiels A, Bennett TM, Knopf HL, Yamada K, Yoshiura K, Niikawa N, Shim S, Hanson PI. 2007. CHMP4B, a novel
gene for autosomal dominant cataracts linked to chromosome 20q. American Journal of Human Genetics
81:596–606. doi: 10.1086/519980.
Shim S, Kimpler LA, Hanson PI. 2007. Structure/function analysis of four core ESCRT-III proteins reveals common
regulatory role for extreme C-terminal domain. Traffic 8:1068–1079. doi: 10.1111/j.1600-0854.2007.00584.x.
Stein JM, Luzio JP. 1991. Ectocytosis caused by sublytic autologous complement attach on human neutrophils.
The Biochemical Journal 274:381–386.
Strack B, Calistri A, Craig S, Popova E, Gottlinger H. 2003. AIP1/Alix is a binding partner for HIV-1 p6 and EIAV
p9 functioning in virus budding. Cell 114:689–699. doi: 10.1016/S0092-8674(03)00653-6.
Sundquist WI, Krausslich HG. 2012. HIV-1 assembly, budding, and maturation. Cold Spring Harbor Perspectives in
Medicine 2:a006924. doi: 10.1101/cshperspect.a006924.
Teis D, Saksena S, Emr SD. 2008. Ordered assembly of the ESCRT-III complex on endosomes is required to
sequester cargo during MVB formation. Developmental Cell 15:578–589. doi: 10.1016/j.devcel.2008.08.013.
Teis D, Saksena S, Judson BL, Emr SD. 2010. ESCRT-II coordinates the assembly of ESCRT-III filaments for cargo
sorting and multivesicular body vesicle formation. The EMBO Journal 29:871–883. doi: 10.1038/emboj.2009.408.
Thery C. 2011. Exosomes: secreted vesicles and intercellular communications. F1000 Biology Reports 3:15.
doi: 10.3410/B3-15.
Van Engelenburg SB, Shtengel G, Sengupta P, Waki K, Jarnik M, Ablan SD, Freed EO, Hess HF, Lippincott-Schwartz J.
2014. Distribution of ESCRT machinery at HIV assembly sites reveals virus scaffolding of ESCRT subunits. Science
343:653–656. doi: 10.1126/science.1247786.
von Schwedler UK, Stuchell M, Müller B, Ward DM, Chung H-Y, Morita E, Wang HE, Davis T, He G-P, Cimbora DM,
Scott A, Kräusslich H-G, Kaplan J, Morham SG, Sundquist WI. 2003. The protein network of HIV budding. Cell
114:701–713. doi: 10.1016/S0092-8674(03)00714-1.
Wemmer M, Azmi I, West M, Davies B, Katzmann D, Odorizzi G. 2011. Bro1 binding to Snf7 regulates ESCRT-III
membrane scission activity in yeast. The Journal of Cell Biology 192:295–306. doi: 10.1083/jcb.201007018.
Wollert T, Hurley JH. 2010. Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature
464:864–869. doi: 10.1038/nature08849.
Wollert T, Wunder C, Lippincott-Schwartz J, Hurley JH. 2009. Membrane scission by the ESCRT-III complex. Nature
458:172–177. doi: 10.1038/nature07836.
Wright ER, Schooler JB, Ding HJ, Kieffer C, Fillmore C, Sundquist WI, Jensen GJ. 2007. Electron cryotomography
of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. The EMBO Journal 26:2218–2226.
doi: 10.1038/sj.emboj.7601664.
Xiao J, Chen XW, Davies B, Saltiel AR, Katzmann D, Xu Z. 2009. Structural basis of Ist1 function and Ist1-Did2
interaction in the multivesicular body pathway and cytokinesis. Molecular Biology of the Cell 20:3514–3524.
doi: 10.1091/mbc.E09-05-0403.
Zamborlini A, Usami Y, Radoshitzky SR, Popova E, Palu G, Gottlinger H. 2006. Release of autoinhibition converts
ESCRT-III components into potent inhibitors of HIV-1 budding. Proceedings of the National Academy of Sciences
of the United States of America 103:19140–19145. doi: 10.1073/pnas.0603788103.

Cashikar et al. eLife 2014;3:e02184. DOI: 10.7554/eLife.02184

17 of 17

